Clearing amyloid through the blood-brain barrier, Journal of Neurochemistry, vol.22, issue.4, pp.807-811, 2004. ,
DOI : 10.1073/pnas.93.9.4229
Clearance of amyloid-?? by circulating lipoprotein receptors, Nature Medicine, vol.23, issue.9, pp.1029-1031, 2007. ,
DOI : 10.1038/nm1635
Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders, Expert Review of Cardiovascular Therapy, vol.1, issue.1, pp.107-119, 2003. ,
DOI : 10.1586/14779072.1.1.107
Von Willebrand factor, platelets and endothelial cell interactions, Journal of Thrombosis and Haemostasis, vol.101, issue.7, pp.1335-1342, 2003. ,
DOI : 10.1182/blood.V98.5.1424
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells, Blood, vol.105, issue.1, pp.145-152, 2005. ,
DOI : 10.1182/blood-2004-02-0464
von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies, Blood, vol.83, pp.3536-3544, 1994. ,
How to Roll an Endothelial Cigar: The Biogenesis of Weibel-Palade Bodies, Traffic, vol.1, issue.2, pp.69-78, 2004. ,
DOI : 10.1006/bbrc.2000.4139
Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.5, pp.1002-1007, 2006. ,
DOI : 10.1161/01.ATV.0000209501.56852.6c
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice, Journal of Thrombosis and Haemostasis, vol.89, issue.3, pp.519-526, 2006. ,
DOI : 10.1073/pnas.061307098
protein???A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions, FEBS Journal, vol.11, issue.21, pp.4831-4841, 2006. ,
DOI : 10.1111/j.1742-4658.2006.05482.x
Fluid Shear Regulates the Kinetics and Receptor Specificity of Staphylococcus aureus Binding to Activated Platelets, The Journal of Immunology, vol.173, issue.2, pp.1258-1265, 2004. ,
DOI : 10.4049/jimmunol.173.2.1258
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus, Blood, vol.96, issue.12, pp.2149-2156, 2000. ,
Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: Preliminary studies, Journal of Vascular Surgery, vol.37, issue.2, pp.433-439, 2003. ,
DOI : 10.1067/mva.2003.63
P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor, Blood, vol.108, issue.12, pp.3746-3752, 2006. ,
DOI : 10.1182/blood-2006-03-010322
Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor, Journal of Cellular Physiology, vol.156, issue.2, pp.714-723, 2005. ,
DOI : 10.1002/jcp.20354
Characterization of the interaction between von Willebrand factor and osteoprotegerin, Journal of Thrombosis and Haemostasis, vol.98, issue.9, pp.1956-1962, 2007. ,
DOI : 10.1111/j.1538-7836.2007.02681.x
The life cycle of coagulation factor VIII in view of its structure and function, Blood, vol.92, issue.17, pp.3983-3996, 1998. ,
Haemophilia A: from mutation analysis to new therapies, Nature Reviews Genetics, vol.92, issue.6, pp.488-501, 2005. ,
DOI : 10.1038/ng1193-236
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR, Annual Review of Biochemistry, vol.67, issue.1, pp.395-424, 1998. ,
DOI : 10.1146/annurev.biochem.67.1.395
Cell Biology of von Willebrand Factor, Annual Review of Cell Biology, vol.6, issue.1, pp.217-246, 1990. ,
DOI : 10.1146/annurev.cb.06.110190.001245
Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes, Haemostasis, vol.3, issue.21, pp.288-295, 1974. ,
Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor, The Journal of Cell Biology, vol.102, issue.4, pp.1320-1324, 1986. ,
DOI : 10.1083/jcb.102.4.1320
Cysteine-mutations in von Willebrand factor associated with increased clearance, Journal of Thrombosis and Haemostasis, vol.96, issue.10, pp.2228-2237, 2005. ,
DOI : 10.1111/j.1538-7836.2005.01571.x
Efficiency of von Willebrand factor-mediated targeting of IL-8 into Weibel-Palade bodies, J Thromb Haemost, issue.24, 2007. ,
Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes, Molecular Biology Reports, vol.13, issue.4, pp.265-275, 1990. ,
DOI : 10.1007/BF00429896
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease, Blood, vol.99, issue.1, pp.180-184, 2002. ,
DOI : 10.1182/blood.V99.1.180
Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide, Thrombosis and Haemostasis, vol.96, pp.290-294, 2006. ,
DOI : 10.1160/TH06-03-0157
A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis, Proceedings of the National Academy of Sciences, vol.95, issue.16, pp.9524-9529, 1998. ,
DOI : 10.1073/pnas.95.16.9524
Amino acid sequence of human von Willebrand factor, Biochemistry, vol.25, issue.11, pp.3171-3184, 1986. ,
DOI : 10.1021/bi00359a015
Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures, J Biol Chem, vol.267, pp.8723-8731, 1992. ,
Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor, J Biol Chem, vol.254, pp.10754-10760, 1979. ,
Primary structure of the majorO-glycosidically linked carbohydrate unit of human von Willebrand factor, Glycoconjugate Journal, vol.14, issue.3, pp.263-270, 1989. ,
DOI : 10.1007/BF01047846
Oligosaccharide structures of von Willebrand factor and their potential role in von Willebrand disease, Blood Reviews, vol.20, issue.2, pp.83-92, 2006. ,
DOI : 10.1016/j.blre.2005.02.002
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?, Transfusion, vol.60, issue.13, pp.1836-1844, 2006. ,
DOI : 10.1046/j.1537-2995.1998.381098440863.x
Factor VIII levels and blood group antigens, Thromb Haemost, vol.50, p.757, 1983. ,
Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis, Blood, vol.106, issue.6, pp.1988-1991, 2005. ,
DOI : 10.1182/blood-2005-02-0792
Amount of H Antigen Expressed on Circulating von Willebrand Factor Is Modified by ABO Blood Group Genotype and Is a Major Determinant of Plasma von Willebrand Factor Antigen Levels, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.2, pp.335-341, 2002. ,
DOI : 10.1161/hq0202.103997
ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens, Thrombosis and Haemostasis, vol.97, pp.534-541, 2007. ,
DOI : 10.1160/TH06-09-0549
Human Umbilical Vein Endothelial Cells Differ from Other Endothelial Cells in Failing to Express ABO Blood Group Antigens, Journal of Vascular Research, vol.37, issue.6, pp.540-547, 2000. ,
DOI : 10.1159/000054087
Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell lines, British Journal of Haematology, vol.68, issue.6, pp.928-931, 2003. ,
DOI : 10.1161/hq0202.103997
Intraplatelet von willebrand factor and ABO blood group, Thrombosis Research, vol.68, issue.4-5, pp.393-398, 1992. ,
DOI : 10.1016/0049-3848(92)90097-T
Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?, Journal of Thrombosis and Haemostasis, vol.74, issue.8, pp.1714-1717, 2003. ,
DOI : 10.1046/j.1538-7836.2003.00359.x
How ABO blood groups affect von Willebrand factor levels in normal subjects, J Thromb Haemost, vol.5, issue.1, 2007. ,
Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans, Blood, vol.88, issue.44, pp.2951-2958, 1996. ,
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival, Blood, vol.108, issue.10, pp.3344-3351, 2006. ,
DOI : 10.1182/blood-2006-04-015065
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis, Journal of Thrombosis and Haemostasis, vol.3, issue.12, pp.2556-2562, 2006. ,
DOI : 10.1111/j.1538-7836.2006.02273.x
Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor antigen levels, British Journal of Haematology, vol.70, issue.2, pp.474-476, 1995. ,
DOI : 10.1007/BF00637604
The half-life of infused factor VIII is shorter in hemophiliac patients with blood group O than in those with blood group A, Thromb Haemost, vol.83, issue.48, pp.65-69, 2000. ,
Recombinant von Willebrand Factor: Preclinical Development, Seminars in Thrombosis and Hemostasis, vol.27, issue.04, pp.395-403, 2001. ,
DOI : 10.1055/s-2001-16892
Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level, British Journal of Haematology, vol.10, issue.2, pp.350-356, 2002. ,
DOI : 10.1046/j.1537-2995.2000.40070856.x
Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein, J Biol Chem, vol.252, issue.51, pp.5538-5546, 1977. ,
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands, Proceedings of the National Academy of Sciences, vol.99, issue.15, pp.10042-10047, 2002. ,
DOI : 10.1073/pnas.142005099
Quantitation of Binding of Ricinus communis Agglutinin I to Von Willebrand Factor (VWF): Investigation of Relationship with Plasma Clearance of VWF in Type 1 Von Willebrand Disease, ASH Annual Meeting Abstracts, vol.106, issue.53, p.727, 2005. ,
The RIIIS/J inbred mouse strain as a model for von Willebrand disease, Blood, vol.76, pp.2258-2265, 1990. ,
A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11, Proceedings of the National Academy of Sciences, vol.93, issue.26, pp.15352-15357, 1996. ,
DOI : 10.1073/pnas.93.26.15352
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort, British Journal of Haematology, vol.266, issue.1, pp.91-99, 2005. ,
DOI : 10.1111/j.1365-2141.2004.05275.x
Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen, J Biol Chem, vol.269, issue.57, pp.15162-15171, 1994. ,
Mvwf, a Dominant Modifier of Murine von Willebrand Factor, Results from Altered Lineage-Specific Expression of a Glycosyltransferase, Cell, vol.96, issue.1, pp.111-120, 1999. ,
DOI : 10.1016/S0092-8674(00)80964-2
O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b., Journal of Clinical Investigation, vol.90, issue.6, pp.2258-2267, 1992. ,
DOI : 10.1172/JCI116112
Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction, Br J Haematol, vol.128, issue.60, pp.82-90, 2005. ,
Clearance of normal and type 2A von Willebrand factor in the rat, Blood, vol.88, pp.1692-1699, 1996. ,
Comparative study of blood group-recognizing lectins toward ABO blood group antigens on neoglycoproteins, glycoproteins and complex-type oligosaccharides, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1525, issue.1-2, pp.50-57, 2001. ,
DOI : 10.1016/S0304-4165(00)00170-7
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels, Blood, vol.109, issue.6, pp.2430-2437, 2006. ,
DOI : 10.1182/blood-2006-06-032706
Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit., Journal of Clinical Investigation, vol.88, issue.3, pp.774-782, 1991. ,
DOI : 10.1172/JCI115376
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, vol.87, issue.65, pp.4223-4234, 1996. ,
Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, vol.87, pp.4235-4244, 1996. ,
Genome-wide linkage analysis of von Willebrand factor plasma levels implicates the ABO locus as a principal determinant: should we overlook ADAMTS13?, Thromb Haemost, vol.90, issue.67, p.961, 2003. ,
Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease, J Thromb Haemost, vol.3, issue.68 1, p.1471, 2005. ,
Clearance mechanisms of von Willebrand factor and factor VIII, Journal of Thrombosis and Haemostasis, vol.25, issue.7, pp.1353-1360, 2007. ,
DOI : 10.1111/j.1538-7836.2005.01571.x
An Experimental Model to Study the in Vivo Survival of von Willebrand Factor: BASIC ASPECTS AND APPLICATION TO THE R1205H MUTATION, Journal of Biological Chemistry, vol.279, issue.13, pp.12102-12109, 2004. ,
DOI : 10.1074/jbc.M310436200
Liver and spleen macrophages contribute to the clearance of von Willebrand factor and its complex with factor VIII, J Thromb Haemost, vol.5, issue.71, 2007. ,
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers, Proceedings of the National Academy of Sciences, vol.104, issue.19, pp.7899-7903, 2007. ,
DOI : 10.1073/pnas.0608422104
SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY, Journal of Thrombosis and Haemostasis, vol.5, issue.1, 2007. ,
DOI : 10.1111/j.1538-7836.2007.tb01780.x
BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII, Journal of Thrombosis and Haemostasis, vol.5, issue.1, p.26, 2007. ,
DOI : 10.1111/j.1538-7836.2007.tb01784.x
A Mathematical Model of Coagulation Factor VIII Kinetics, Pathophysiology of Haemostasis and Thrombosis, vol.26, issue.6, pp.289-303, 1996. ,
DOI : 10.1159/000217222
High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII, Thrombosis and Haemostasis, vol.92, issue.76, pp.42-46, 2004. ,
DOI : 10.1160/TH04-02-0063
Stoichiometry of the porcine factor VIII-von Willebrand factor association, J Biol Chem, vol.262, issue.77, pp.17572-17576, 1987. ,
The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII, Biochemical Journal, vol.257, issue.3, pp.679-683, 1989. ,
DOI : 10.1042/bj2570679
Biochemical and functional characterization of chemically modified recombinant von Willebrand factor (rVWF) as a carrier prolonging survival of rFVIII in hemophilia A knock-out mice, J Thromb Haemost, vol.5, issue.79, 2007. ,
Modification of rVWF with Polysialic Acid: Biochemical and Functional Characterization in Mice with VWD, ASH Annual Meeting Abstracts, vol.108, p.1001, 2006. ,
Structure-Immunogenicity Relationships of Therapeutic Proteins, Pharmaceutical Research, vol.21, issue.6, pp.897-903, 2004. ,
DOI : 10.1023/B:PHAM.0000029275.41323.a6
Pegylation: Engineering Improved Biopharmaceuticals for Oncology, Pharmacotherapy, vol.77, issue.8 Part 2, pp.3-8, 2003. ,
DOI : 10.1517/13543784.10.12.2201
Pegylation protects factor VIII from the inhibition of antibody inhibitors, J Thromb Haemost, vol.5, issue.83 1, p.36, 2007. ,
Recombinant human thrombopoietin: basic biology and evaluation of clinical studies, Blood, vol.100, issue.10, pp.3457-3469, 2002. ,
DOI : 10.1182/blood.V100.10.3457
Factor VIII half-life and clinical phenotype of severe hemophilia A, Haematologica, vol.90, issue.85, pp.494-498, 2005. ,